Search

everythinglearnresearchcommunity

for

Search:↓

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Scalp lesions in discoid lupus are more common in women and linked to other autoimmune diseases.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Iron deficiency common in women, not always linked to hair loss; more research needed.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.